TipRanks
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market
HBIO
Harvard Bioscience
RESEARCH TOOLSreports
Want to see HBIO full AI Analyst Report?

Harvard Bioscience (HBIO) Ratios

278 Followers

Harvard Bioscience Ratios

HBIO's free cash flow for Q2 2026 was $0.56. For the 2026 fiscal year, HBIO's free cash flow was decreased by $ and operating cash flow was $-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.87 2.20 0.82 1.85 2.20
Quick Ratio
 0.98 1.25 0.40 0.92 1.06
Cash Ratio
 0.26 0.39 0.07 0.16 0.19
Solvency Ratio
 -0.06 -0.77 -0.09 0.06 -0.03
Operating Cash Flow Ratio
 0.03 0.31 0.03 0.53 0.05
Short-Term Operating Cash Flow Coverage
 0.00 4.41 0.04 2.39 0.30
Net Current Asset Value
$ -22.41M$ -18.11M$ -18.19M$ -15.25M$ -22.02M
Leverage Ratios
Debt-to-Assets Ratio
 0.58 0.55 0.35 0.31 0.37
Debt-to-Equity Ratio
 5.96 3.22 0.70 0.59 0.75
Debt-to-Capital Ratio
 0.86 0.76 0.41 0.37 0.43
Long-Term Debt-to-Capital Ratio
 0.83 0.72 0.00 0.30 0.37
Financial Leverage Ratio
 10.28 5.83 2.00 1.88 2.01
Debt Service Coverage Ratio
 -0.24 -7.12 -0.06 0.76 0.10
Interest Coverage Ratio
 0.30 -0.13 -1.94 0.53 -2.72
Debt to Market Cap
 1.02 1.26 0.40 0.16 0.41
Interest Debt Per Share
 10.52 11.08 10.96 1.09 1.37
Net Debt to EBITDA
 -40.15 -0.77 -27.40 4.79 52.68
Profitability Margins
Gross Profit Margin
58.16%53.01%58.18%58.86%53.66%
EBIT Margin
-8.15%-60.62%-8.98%0.92%-5.85%
EBITDA Margin
-1.07%-53.75%-1.57%7.16%0.83%
Operating Profit Margin
1.17%-0.73%-6.60%1.69%-6.12%
Pretax Profit Margin
-12.00%-66.30%-12.39%-2.28%-8.10%
Net Profit Margin
-11.86%-65.51%-13.18%-3.04%-8.40%
Continuous Operations Profit Margin
-11.86%-65.51%-13.18%-3.04%-8.40%
Net Income Per EBT
98.78%98.80%106.34%133.61%103.67%
EBT Per EBIT
-1026.39%9123.37%187.81%-134.95%132.40%
Return on Assets (ROA)
-13.65%-70.81%-9.80%-2.49%-6.55%
Return on Equity (ROE)
-92.01%-412.84%-19.58%-4.67%-13.18%
Return on Capital Employed (ROCE)
1.99%-1.08%-8.66%1.71%-5.68%
Return on Invested Capital (ROIC)
1.91%-1.04%-5.66%1.60%-5.41%
Return on Tangible Assets
-17.14%-90.18%-20.96%-5.31%-13.98%
Earnings Yield
-27.58%-190.92%-13.50%-1.50%-8.30%
Efficiency Ratios
Receivables Turnover
 6.06 5.39 6.33 6.97 6.78
Payables Turnover
 5.90 11.14 8.22 8.31 8.15
Inventory Turnover
 1.65 1.95 1.69 1.87 1.99
Fixed Asset Turnover
 7.47 18.08 8.38 12.82 12.34
Asset Turnover
 1.15 1.08 0.74 0.82 0.78
Working Capital Turnover Ratio
 3.88 10.54 14.88 4.46 3.53
Cash Conversion Cycle
 219.28 221.61 228.77 203.81 192.75
Days of Sales Outstanding
 60.27 67.66 57.64 52.35 53.80
Days of Inventory Outstanding
 220.84 186.73 215.51 195.36 183.76
Days of Payables Outstanding
 61.83 32.78 44.38 43.90 44.81
Operating Cycle
 281.12 254.39 273.15 247.70 237.56
Cash Flow Ratios
Operating Cash Flow Per Share
 0.14 1.52 0.33 0.33 0.03
Free Cash Flow Per Share
 -0.31 1.26 -0.42 0.28 -0.01
CapEx Per Share
 0.46 0.25 0.75 0.05 0.04
Free Cash Flow to Operating Cash Flow
 -2.18 0.83 -1.27 0.84 -0.38
Dividend Paid and CapEx Coverage Ratio
 0.31 6.04 0.44 6.07 0.72
Capital Expenditure Coverage Ratio
 0.31 6.04 0.44 6.07 0.72
Operating Cash Flow Coverage Ratio
 0.01 0.15 0.03 0.33 0.02
Operating Cash Flow to Sales Ratio
 <0.01 0.08 0.02 0.12 0.01
Free Cash Flow Yield
-3.75%18.91%-1.98%5.16%-0.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.44 -0.52 -7.54 -66.46 -12.05
Price-to-Sales (P/S) Ratio
 0.41 0.34 0.98 2.02 1.01
Price-to-Book (P/B) Ratio
 4.88 2.16 1.45 3.11 1.59
Price-to-Free Cash Flow (P/FCF) Ratio
 -25.55 5.29 -50.39 19.37 -261.90
Price-to-Operating Cash Flow Ratio
 55.79 4.41 63.80 16.18 99.58
Price-to-Earnings Growth (PEG) Ratio
 -0.05 >-0.01 -0.03 1.02 >-0.01
Price-to-Fair Value
 4.88 2.16 1.45 3.11 1.59
Enterprise Value Multiple
 -78.58 -1.40 -89.72 33.04 174.20
Enterprise Value
 75.32M 65.36M 132.25M 265.44M 164.45M
EV to EBITDA
 -80.21 -1.40 -89.72 33.04 174.20
EV to Sales
 0.86 0.76 1.40 2.36 1.45
EV to Free Cash Flow
 -53.34 11.64 -72.55 22.65 -375.45
EV to Operating Cash Flow
 116.05 9.71 91.84 18.92 142.75
Tangible Book Value Per Share
 -1.80 -0.78 -0.95 >-0.01 -0.12
Shareholders’ Equity Per Share
 1.64 3.09 14.55 1.72 1.74
Tax and Other Ratios
Effective Tax Rate
 0.01 0.01 -0.06 -0.34 -0.04
Revenue Per Share
 19.40 19.50 21.62 2.65 2.74
Net Income Per Share
 -2.30 -12.77 -2.85 -0.08 -0.23
Tax Burden
 0.99 0.99 1.06 1.34 1.04
Interest Burden
 1.47 1.09 1.38 -2.47 1.38
Research & Development to Revenue
 0.10 0.10 0.11 0.10 0.11
SG&A to Revenue
 0.43 0.43 0.46 0.20 0.22
Stock-Based Compensation to Revenue
 0.01 -0.02 0.05 0.04 0.04
Income Quality
 -0.06 -0.12 -0.12 -4.11 -0.12
Currency in USD